TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $256,700 | +122723.0% | 171,214 | -18.5% | 0.00% | – |
| Q4 2022 | $209 | -100.0% | 210,118 | -35.9% | 0.00% | – |
| Q3 2022 | $590,000 | +54.9% | 327,948 | +149.6% | 0.00% | – |
| Q2 2022 | $381,000 | +11.4% | 131,393 | +6.0% | 0.00% | – |
| Q1 2022 | $342,000 | -42.0% | 123,951 | -2.0% | 0.00% | – |
| Q4 2021 | $590,000 | -49.4% | 126,536 | -7.8% | 0.00% | – |
| Q3 2021 | $1,167,000 | -84.0% | 137,183 | -69.2% | 0.00% | -100.0% |
| Q2 2021 | $7,316,000 | -5.5% | 445,815 | +27.1% | 0.00% | -33.3% |
| Q1 2021 | $7,741,000 | +118.5% | 350,684 | +206.2% | 0.00% | +200.0% |
| Q4 2020 | $3,543,000 | +282.6% | 114,530 | +150.7% | 0.00% | – |
| Q3 2020 | $926,000 | – | 45,691 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |